Next Article in Journal
Thick Mucus in ALS: A Mixed-Method Study on Associated Factors and Its Impact on Quality of Life of Patients and Caregivers
Next Article in Special Issue
Relationship between Behavioral and Objective Measures of Sound Intensity in Normal-Hearing Listeners and Hearing-Aid Users: A Pilot Study
Previous Article in Journal
The Development of a Multi-Modality Emotion Recognition Test Presented via a Mobile Application
Previous Article in Special Issue
Increased Threshold and Reduced Firing Rate of Auditory Cortex Neurons after Cochlear Implant Insertion
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Frequency Fitting Optimization Using Evolutionary Algorithm in Cochlear Implant Users with Bimodal Binaural Hearing

by
Alexis Saadoun
1,
Antoine Schein
1,
Vincent Péan
2,
Pierrick Legrand
3,
Ludwig Serge Aho Glélé
4 and
Alexis Bozorg Grayeli
1,5,*
1
Department of Otolaryngology—Head and Neck Surgery, Dijon University Hospital, 21000 Dijon, France
2
Clinical Support Department, MED-EL, 75012 Paris, France
3
Institute of Mathematics of Bordeaux, UMR CNRS 5251, ASTRAL Team, Inria Bordeaux Sud-Ouest, University of Bordeaux, 33405 Talence, France
4
Department of Hospital Epidemiology and Infection Control, Dijon University Hospital, 21000 Dijon, France
5
ImVia Research Laboratory, Bourgogne-Franche Comté University, 21000 Dijon, France
*
Author to whom correspondence should be addressed.
Brain Sci. 2022, 12(2), 253; https://doi.org/10.3390/brainsci12020253
Submission received: 28 November 2021 / Revised: 26 January 2022 / Accepted: 28 January 2022 / Published: 11 February 2022
(This article belongs to the Special Issue Advances in Hearing Loss Diagnosis and Management)

Abstract

:
Optimizing hearing in patients with a unilateral cochlear implant (CI) and contralateral acoustic hearing is a challenge. Evolutionary algorithms (EA) can explore a large set of potential solutions in a stochastic manner to approach the optimum of a minimization problem. The objective of this study was to develop and evaluate an EA-based protocol to modify the default frequency settings of a MAP (fMAP) of the CI in patients with bimodal hearing. Methods: This monocentric prospective study included 27 adult CI users (with post-lingual deafness and contralateral functional hearing). A fitting program based on EA was developed to approach the best fMAP. Generated fMAPs were tested by speech recognition (word recognition score, WRS) in noise and free-field-like conditions. By combining these first fMAPs and adding some random changes, a total of 13 fMAPs over 3 generations were produced. Participants were evaluated before and 45 to 60 days after the fitting by WRS in noise and questionnaires on global sound quality and music perception in bimodal binaural conditions. Results: WRS in noise improved with the EA-based fitting in comparison to the default fMAP (41.67 ± 9.70% versus 64.63 ± 16.34%, respectively, p = 0.0001, signed-rank test). The global sound quality and music perception were also improved, as judged by ratings on questionnaires and scales. Finally, most patients chose to keep the new fitting definitively. Conclusions: By modifying the default fMAPs, the EA improved the speech discrimination in noise and the sound quality in bimodal binaural conditions.

1. Introduction

Stereophony is based on combining information in the brain from the two ears. The brain makes use of many different cues to determine the 3D characteristics of an auditory landscape [1]. Their complete combination is required for stereophony to be achieved, but access to only some bilateral cues may still generate substantial benefits.
Advantages of binaural stimulation, as opposed to monaural hearing, are (1) redundancy (summation effect) which enhances the signal detection; (2) localization of the sound-source (in the horizontal plane) based on inter-aural time differences (ITD) and level differences (ILD); and (3) improved speech discrimination in noise when signal and noise are spatially separated (squelch effect).
Moreover, with binaural hearing, the head-shadow increases the signal-to-noise ratio at the farthest ear from the noise (as the head attenuates the noise), while this ratio decreases at the nearest ear to the noise source.
Bimodal binaural hearing refers to the use of a cochlear implant (CI) in one ear in combination with a functional acoustic hearing with or without a hearing aid (HA) on the contralateral side. This association provides adults and children with improved speech perception in quiet and in noise, better music perception, auditory comfort, higher sound quality, enhanced sound localization, and as a result, a better quality of life in comparison to unilateral CI [2,3,4,5]. The improvements are related to the integration of the electric hearing, offering auditory information in a relatively broad frequency range (between 0.07 and 8.5 kHz depending on the brand), and the contralateral acoustic input offering the acoustic fine-structure cues. In addition, bimodal hearing reduces the head-shadow effect due to single-sided deafness (SSD) and restores the binaural squelch and summation effects to some extent [3,6].
However, there is great variability in the integration process; while some bimodal users show substantial benefit, others receive little or no advantage.
This variability could be due to the characteristics of the individual listeners (neural survival, current spread, duration of deafness, lack of cortical plasticity), to different processing times between CI and contralateral HA or NH ear [7], to frequency mismatch between the CI and the contralateral HA or NH ear [8], or differences between automatic gain control (AGC) of the CI and the HA [9]. The latter three parameters could be rectifiable via signal processing and/or mapping [10].
Some patients experience even bimodal interference and report better hearing with one of the ears [11,12,13,14,15]. The possibility of this interference is further supported by the observation that in patients with bimodal binaural hearing, the deactivation of apical CI electrodes coding for frequencies perceived by the aided contralateral ear produces a more natural and less metallic sound without reducing the word discrimination in quiet and in noise [16]. In this case, binaural interactions were apparently improved by suppressing the temporal and/or frequency mismatch in the low frequencies at the cost of reduced cochlear implant performance.
Alternatively, binaural interactions could be improved through frequency band adjustments without electrode deactivation [10], or through adjustment of the temporal processing between the CI and the contralateral HA or ear [7,17].
The facility to obtain the bimodal integration appears to influence the auditory outcome [18]. Apart from patient-related factors, such as deprivation duration or a number of functional channels in the implanted ear, device-dependent factors, such as the asynchronous CI and acoustic inputs, different sound preprocessing strategies in the CI and the HA, or loudness and pitch mismatches can affect the speed and the quality of this integration [18].
Based on these findings, an improvement of the spatial CI coding, which relies on the cochlear tonotopy, could theoretically improve the binaural integration. The Greenwood map offers a relatively precise function describing the physiological place-frequency relation in the human cochlea [19]. With CI, the place-frequency function is different from the physiological cochlear tonotopy and a high inter-individual variability exists since the coverage of the cochlear duct by the electrode array is partial and variable. With time and training, a tolerance to the shift between the electric and acoustic stimuli in terms of temporal and spatial coding appears [18]. In many implantees, a perceptual fusion is observed for two sounds with very different pitches presented simultaneously to both ears [20,21].
In a standard CI fitting, the default frequency allocations to active electrodes are not modified and only the sensation of loudness is adjusted [22,23]. Modifying the frequency allocations may improve speech discrimination and music perception [18,24,25], but this type of fitting would involve too many parameters and is not practiced in routine [26]. Moreover, its effect on bimodal binaural patients has not been reported to our knowledge.
We hypothesized that reallocating the frequency bands in the CI would lead to a better fusion of the central binaural information, an improved hearing in noise, and a higher sound quality in bimodal binaural conditions. Binaural redundancy is one of the binaural advantages that could be addressed with bimodal rehabilitation. Binaural redundancy could increase loudness via binaural summation but could also improve the detection threshold and frequency differences, and as a result, the speech recognition in noise [1]. Adults who use bimodal hearing devices seem to benefit from the binaural redundancy [3,12,27] but not always [28]. An inter-aural mismatch may significantly limit this effect. In NH subjects listening to bilateral CI simulations with varying virtual electrode positions [29], the maximum binaural summation benefit for speech in quiet and in noise was observed when the inter-aural mismatch of the virtual electrode positions was ≤1 mm.
Moreover, inter-aural mismatch has also been shown to limit speech understanding in noise when signal and noise are spatially separated [10,30]. This is due to distortions of ITD and ILD [31,32].
A place-matched frequency mapping based on electrode location could be hampered by the difficulty to determine the amount of neural survival or local electric stimulation interactions in the cochlea for an individual [10,33]. ITD was used to evaluate inter-aural place mismatch [31,33] and the results were close in accordance with CT scan estimates, but the studies were limited to SSD and bilateral CI patients. No study has been carried out with bimodal patients with CI and contralateral HA.
In the bimodal context, patients wear a HA on the contralateral ear with various signal processing programs (number of channels, frequency bandwidths, etc.). Since the number of fitting combinations is very high, artificial intelligence can be employed to search this vast domain for the best solution.
Evolutionary algorithms (EA) are a family of algorithms inspired by Darwin’s theory of evolution [34,35]. Initial individuals, represented in our case by the set of frequency ranges for all electrodes (fMAPs), are submitted to the constraint of the environment (i.e., audiometric scores). Their adaptation, stochastic mixing of their genes (i.e., frequency band allocations), and the possibility of mutation (stochastic changes in the fMAP) yield offspring (new fMAPs) generation after generation (iterations). Each fMAP is submitted to an evaluation by a speech audiometric test in noise to obtain a score for each fMAP, represented by a word recognition score (WRS) out of ten. Based on this score, the best solutions are selected and combined to obtain more performant fMAPs. These algorithms provide a wide exploration of solutions in a predefined domain that could not otherwise be conducted in a timely fashion, even by an expert [36]. By comparison, the existing deterministic and probabilistic algorithms, such as the one used in the only computer-based fitting aid, the Fitting to Outcome Expert (FOX) system, tend to modify the settings to approach an ideal situation with predefined parameters (T- and M-levels, gains, [37,38]). Moreover, the frequency bands are not considered as a parameter [38].
The objective of the present study was to develop and evaluate a fitting protocol based on the CI frequency reallocation for bimodal binaural CI users with different CI brands using an interactive EA method.

2. Materials and Methods

2.1. Participants

Twenty-seven adults (10 men, 17 women) volunteered to participate in this monocentric and prospective study. All participants were unilateral CI users for a minimum of 6 months with functional contralateral hearing (normal hearing or HA). Their mean age was 58 ± 16.7 years (median: 64, range: 20–80 years). The average duration of the deafness before CI was 23.5 ± 15.8 years (median: 19, range: 1–55 years). In the implanted ear, patients wore various brands of CIs and coding strategies. In the contralateral ear, 23 participants wore a behind-the-ear HA which was fitted with a NAL-NL1 protocol and checked by their audiologist within the 3-month period before inclusion. Three participants had contralateral normal hearing (Table 1).

2.2. Experimental Setup

At inclusion, the clinical and audiometric data were obtained, and each CI was fitted with an fMAP based on the EA. Other fMAPs already available on the processor were left unmodified. Participants were asked to use the EA-based fMAP as much as possible, but they were free to switch to their usual fMAPs ad lib. The second session was conducted 45 to 60 days later. Patients were again evaluated with a pure-tone, speech recognition test in quiet and noise in free-field-like conditions and questionnaires. The main criterion of the study was the improvement of the word recognition score (WRS) in noise with EA-based fMAP.

2.3. Audiometry

All evaluations were performed in the bimodal binaural condition in an audiometry booth with a calibrated audiometer (AC40®, Interacoustics, Middelfart, Denmark). The signal was delivered by a loudspeaker (Planet M, Elipson, Champigny, France) placed at the level of the head 1 m in front of the participant.
French Fournier lists were used for the speech audiometry in this study [44].
At the initial and the final evaluation, the audiometry tests included:
  • A pure-tone audiometry in free-field-like condition;
  • A speech recognition test in quiet with monosyllabic words providing the WRS in quiet;
  • A speech recognition test in noise: both signal and noise (white noise at 60 dB SPL) were delivered by the same loudspeaker;
  • In a preliminary trial with different lists of 20 words, the signal-to-noise ratio (SNR) was individually adapted (−7, 0, +5, or +10 dB) to obtain a percentage of WRS between 3/10 and 7/10. Every patient kept its individually adapted SNR at the same level through the follow-up. Two series of words were also administered for the initial and the final evaluations.
During the EA-based fitting, each generated fMAP was tested with a different series of 10 words to obtain a WRS in noise out of ten at the same level of SNR used for the evaluations.
No feedback was provided during speech recognition tests.
The improvement of the WRS in noise on 20 words at the initial and at the final evaluation was the main judgment criterion of the study.

2.4. Questionnaires

We also asked the participants to complete a quality-of-hearing questionnaire, APHAB (Abbreviated Profile of Hearing Aid Benefit) in its French version related to their handicap before and after the new CI fitting [45]. The questionnaire includes 24 questions on different everyday-life situations related to hearing function. They are divided into 4 categories: Ease of Communication (EC), Reverberation (RV), Background Noise (BN, communication in environments with high background noise), and Aversiveness (AV). It provides a global score and 4 subdomain scores. The Hearing Implant Sound Quality Index score (HISQUI19, [46]) comprises 19 questions on the sound quality perceived by the CI. Scores range from 19 (poor) to 133 points (excellent). In addition, a shortened Munich Music questionnaire (MMQ) [47] was administered including categorical ratings of “metallic”, “clear”, “pleasant”, and “natural” qualities of the musical sounds plus the following questions with forced categorical responses: How long do you listen to music since the last CI fitting? (<30 min/30–60 min/60–120 min/ >120 min); Can you distinguish between high and low notes? (Yes/no); Do you normally feed music directly into your speech processor? (Yes/no). Finally, patients rated the global sound quality by a Likert scale (natural sound and voices, auditory comfort in silence and in noise; scores ranging from 1, “not at all” to 5, “totally agree”).

2.5. Frequency Reallocation with the Evolutionary Algorithm

Evolutionary algorithms are calculation methods based on biological evolution. Among this family of algorithms, the most popular are genetic algorithms [48,49,50,51,52,53]. In this paper, we propose a hybrid algorithm at the intersection of a genetic algorithm and an evolutionary strategy. Indeed, we will manipulate real values and apply Gaussian mutations derived from evolutionary strategies, but we will also perform locus type crossovers, which are usually used in genetic algorithms. Finally, since the evaluation step is carried out without a mathematical evaluation function, but only based on the hearing test results, we consider this approach as an interactive evolutionary algorithm.
The general idea is to bring changes to a set of solutions in the optics of improving them by gradual changes and the assessment of the effects of these changes. During this process, the initial values can be changed randomly in a predefined range, especially to generate the initial set of solutions (parents). Later, limited random changes are also introduced in the process to create new solutions (crossover and mutations). This characteristic classes the evolutionary algorithms as stochastic [54]. This algorithm employs alternatively, the mathematical operators of initiation, evaluation, variation (by combination and mutation), selection, and replacement. Solutions (fMAPs in our study) are generated by combining the parent solutions based on their performance (speech recognition test in noise). Mathematically, the algorithm attempts to find the shortest way to the highest performance. It considers the previous combinations and their results to propose new solutions.
The general procedure was as follows (Figure 1 and Figure 2):
  • Input default settings to define the boundaries of the exploration space: exploration domain for each band was set at the lower limit of the same band (fLOW) to 1.2 times the upper limit (1.2 × fHIGH);
  • Random generation of an initial population in the range allowed for each electrode: 4 parents (i.e., 4 fMAPs P1, P2, P3, P4);
  • Evaluation of P1 to P4 by speech recognition in noise. Each fMAP obtains a score: SP1, SP2, SP3, SP4;
  • Input SP1 to 4;
  • Evolutionary loop, until stop-criteria (number of generations = 3 in our study):
    • Generation of children (3 individuals, first loop: C1, C2, C3);
    • Selection of 2 individuals among the previous generation by tournament: Two individuals of the previous generation are randomly selected; the one with the highest probability is chosen. The previous process is repeated. In this way, two individuals are finally selected;
    • Crossover: combining electrode settings from 2 parent fMAPs to obtain a child;
    • Gaussian mutation: mutations can be applied to fLOW and fHIGH with a probability Pm in the predefined range;
    • Evaluation of the 3 children by WRS yielding scores SCn (first loop: SC1, SC2, SC3);
    • Input SCn;
    • Selection of 4 individuals with the highest WRS among all generated individuals (for the first loop: 7 fMAPS, P1 to P4, and C1 to C3).
  • Output: The best fMAP (highest WRS) obtained during the evolutionary process.
The algorithm was developed using MATLAB (2016a version, MathWorks, Natick, MA, USA) as described before [35]. In this algorithm, each fMAP represented an individual. The default fMAP (factory settings) was used to define the initial frequency bands. Initial fMAPs were generated by EA-based on these initial values. For a new fMAP, the upper limit of each frequency band (fHIGH) was determined by the EA in an exploration domain ranging from the lower limit of the same band (fLOW) to 1.2 × fHIGH (Figure 1).
Discontinuities and overlaps in the frequency domain were not permitted. Consequently, The fLOW of each frequency band was set equal to the fHIGH of the previous band. Larger values of overlapping and mutation probability would have created a total disruption of the original fMAP, requiring longer adaptation periods, a larger exploration domain with more generations, and longer tests. With these constraints, the default fMAP generated a random initial population of 4 parent fMAPs (Figure 2).
Each new fMAP was evaluated by WRS in noise (/10) and the result was fed to the algorithm. Two parent MAPs were randomly selected using a tournament selection. The best fMAP (based on WRS) became the first parent and the repetition of the same procedure produced the second parent. These two parents generated a child fMAP by combining their frequency bands (crossover) and applying mutations. During the combination, a variable proportion of the available frequency bands from one parent were combined with those from the second parent to form a new set of frequency bands for the offspring. The combination process did not modify the upper and lower frequency band limits. For the generation of child-fMAPs mutation was applied.
During a mutation, the upper-frequency band limit was modified in a stochastic manner. This modification was limited to the exploration domain [fLOW, 1.2 × fHIGH]. The mutation probability for a frequency band in each generated fMAP was set at 0.2, with a standard deviation of 0.1 × frequency band width (Gaussian mutation). The tournament selection was repeated 2 more times to generate 2 other couples of parent MAPs. For these selections, a sampling with replacement strategy was employed. Crossbreeding of each couple produced a child fMAP. Hence, the first generation of 3 child-fMAPs was created and tested by WRS in noise. To create the second generation, 4 parents were selected from 7 already generated fMAPs (4 parents and 3 children). The selection and crossbreeding generated 3 children for the second generation. Finally, for the third generation, 4 parents were selected from 10 generated fMAPs (4 parents and 6 children), and 3 children were obtained. The process was stopped after 3 generations. In total, 13 fMAPs including 4 parents and 9 children over 3 generations, were produced. In the end, the fMAP with the highest WRS was selected. In the case of 2 fMAPs with the same score, the one preferred by the patient based on sound quality was selected. This algorithm differed from the general scheme by the fact that the optimization cycle was halted after 3 generations, and not when an optimization criterion was reached. This specificity was imposed by the length of the procedure and the necessity of multiple speech audiometries, which could not be increased indefinitely.

2.6. Fitting Software Programs

BEPS+ research software (Advanced Bionics Research Center, Hannover, Germany) was used for frequency allocation in Advanced Bionics CIs. For all other CIs, routine clinical software was used. The minimal frequency fitting step was 1 Hz for MED-EL and Cochlear CIs, 62 Hz for Advanced Bionics CIs, and 131 Hz for the Oticon Medical CI. For Advanced Bionics and Oticon CIs, the closest frequency increments to the provided fMAP were selected. The minimum frequency band width was 62 Hz for Advanced Bionics and Cochlear CIs, 1 Hz for MED-EL CIs, and 131 Hz for the Oticon Medical CI. These values are obligatory and inherent to the fitting software, the coding strategy, or both.

2.7. Determination of Greenwood Frequency MAP in Individual Cochleae

The postoperative CT scans were analyzed with Osirix (V4, Pixmeo, Geneva, Switzerland). The length of the cochlea from the round window (RW) to the apex and the position of each electrode from the apex were measured in millimeters (Figure 3). A tridimensional curved multiplanar reconstruction was created. The relative position of each electrode to the apex was expressed as the ratio of the distance between the electrode and the RW to the estimated length of the basilar membrane (in mm). The Greenwood equation was then applied to determine the corresponding tonotopic frequency [19]: F = 165.4 (102.1X − 0.88) where F is the frequency (Hz) and X is the relative distance of the electrode from the round window (distance from round window/entire length of the basilar membrane).

2.8. Statistics

Power calculations were carried out by G*Power (v. 1.3.6.9, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany, [55]). Based on reported studies on speech discrimination in noise in bimodal binaural patients, the inter-individual performance variability was estimated as 20% and a 15% variation of the WRS after EA-based fitting was anticipated. With β = 0.05, and α = 0.05, and for a two-tailed non-parametric paired comparison, 27 participants were required. All patients were included in an intention-to-treat analysis.
Statistical tests were conducted on Prism, version 8, GraphPad Software, San Diego, CA, USA, 2018. Paired comparisons of continuous variables with non-normal distributions were analyzed by Wilcoxon signed-rank test, and the results were expressed as mean ± standard error of mean, median, and range. ANOVA or mixed-model analysis were employed to compare center frequencies deduced from EA to those obtained from the Greenwood MAPs and the manufacturer’s default settings. Their normal distribution was verified by D’Agostino and Pearson’s test. The results were expressed as mean ± standard error of mean. A p-value < 0.05 was considered significant.

3. Results

All 27 participants performed the first and the second evaluation sessions and fully completed all evaluation steps. The average duration of the fitting session was 135 ± 30 min. Subjects 2 and 4 (Table 1) did not accept to finish the fitting due to the duration of the test: subject 2 completed the procedure up to the first fMAP of the second generation (8 fMAPs in total) and subject 4 completed the second fMAP of the first generation (6 fMAPs). In patients with MED-EL CIs, the most basal electrodes were deactivated because of a high impedance (patient 1 and 2: electrodes #12, patient 16: electrodes #11 and #12) or a vestibular response (patient 5: electrode #12). For subject 6 (Oticon Medical), the 3 most apical electrodes were deactivated during the first postoperative months because of unpleasant sounds. For the patient with Cochlear CIs, electrode #15 was deactivated because of high impedance (patient 10), and electrodes #1-5 were deactivated because of a vestibular response or no response (Patient 27). The fMAP proposed by the EA excluded the deactivated electrodes as a precondition.

3.1. Frequency Band Adjustments with Evolutionary Algorithm

The algorithm suggested a different frequency allocation per electrode than the default setting. The EA yielded an enlargement of the bands in the low frequencies (4 most apical electrodes, Figure 3). Moreover, the EA shifted the center frequencies (Fc) of these apical electrodes toward higher values regardless of CI brand or the number of available electrodes (Figure 4).
In patients with Cochlear or Advanced Bionics CIs, several frequency bands were dramatically narrowed while the bands allocated to the neighboring electrodes were significantly widened, suggesting the detection and the resolution of channel interferences (e.g., electrode 16 in patient 3, Appendix A).
A postoperative CT scan was available for 15 patients (6 MED-EL, 2 Advanced Bionics, and 7 Cochlear). The center frequencies deduced from the Greenwood map were compared to those from the EA and the default fMAPs (Figure 5, Appendix B). Both EA-based and default fMAPs yielded lower center frequencies than the Greenwood map.

3.2. Audiometry

The best fMAP was not always obtained at the last generation (Table 2). In 6 patients, the first generation of fMAPs (parents), which were generated randomly in the predefined domain, yielded the best results. In the remaining cases, the best fMAP was among the first (n = 7), the second (n = 6), or the third (n = 8) generations. In 9 patients, several fMAPs yielded the same optimal WRS (patients 2–4, 8, 9, 11, 20, 21, 24). In these cases, the patient chose the fMAP among those with the highest WRS based on subjective quality of sound.
At the final evaluation, WRS in noise was significantly improved with EA (4.17 ± 0.97, median: 3.5, range: 2–5, with the default fMAP versus 6.46 ± 1.63, median: 7, range: 2–9 with the EA-based fMAP, n = 27, p = 0.0001, Wilcoxon sign-ranked test). The duration of hearing deprivation was not correlated to the initial or the final WRS (linear regression test, not significant, data not shown). At the final evaluation, the WRS in quiet remained unchanged (9.04 ± 2.01 initially, median: 10, range: 2–10 versus 9.22 ± 1.76, median 10, range 3–10 at the final test, n = 27, non-significant, Wilcoxon sign-ranked test). Similarly, the EA-based fitting did not alter the pure-tone average in the free-field-like condition (20.9 ± 9.4 dB HL, median: 20, range: 1.3–47.5, for the initial fitting versus 19 ± 7.2 dB, median 20, range: 1.3–32.5 at the final test, n = 27, non-significant, Wilcoxon sign-ranked test).

3.3. APHAB Questionnaire

The quality of hearing, as assessed by APHAB, was significantly improved (50.4 ± 16.6, median: 55.5, range: 24.1–73.2, for the global score before versus 43.5 ± 16.8, median: 46.6, range: 10.2–66.6, after the EA fitting, n = 27, p = 0.002 Wilcoxon sign-ranked test). The quality of hearing was also significantly improved in EC, RV, and BN APHAB subdomains (Figure 6).

3.4. HISQUI Questionnaire

The quality of hearing, as assessed by HISQUI, was significantly improved (72.2 ± 17.7, median: 70, range: 44–116 before versus 77.9 ± 21.5, median: 75, range: 45–121, after the EA fitting, n = 27, p = 0.034 Wilcoxon sign-ranked test).

3.5. Global Evaluation of the Sound Quality and Music Perception

The music perception quality as evaluated by the MMQ rating, as well as the global sound quality, did not change, as judged by the Likert scale (Figure 7). Where 23 out of 27 participants (85%) preferred the new EA-based fitting to their previous fitting by the expert and chose to keep it after the study.

4. Discussion

Optimizing the fitting in CI users with bimodal binaural hearing can be challenging due to a high number of fitting parameters and combinations. We showed that the frequency band distribution by EA improves not only speech discrimination in noise but also the hearing-related quality of hearing, as judged by APHAB and HISQUI questionnaires. The EA-based fitting resulted in a widening of the frequency bands in the low frequencies and a global shift to higher frequencies than those proposed in the default setting, even farther from the original cochlear tonotopy. There were also individual alterations to the default fMAP, presumably depending on specific electrode nerve interactions. Neural survival and current spread could be reflected by these individual alterations because the measures used for the EA were evaluated directly on the patient and were dependent on its extrinsic characteristics [10]. The method was applicable to all different CI brands.
Speech recognition in noise is probably the most challenging and also one of the most relevant tasks for patients with hearing loss [2]. In case of bimodal or SSD patients, the intersubject variability for binaural results are very large [8]. Wess et al. proposed several possible explanations possible for this variability: (1) intrisinc characteristics of the individual listeners (neural survival, current spread, duration of deafness, lack of cortical plasticity) that cannot be addressed through signal processing; (2) extrinsic distorsions rectifiable via signal processing and/or mapping procedures including different processing times between CI and contralateral HA or NH ear and frequency mismatch between the CI and the contralateral HA or NH ear [10]. For example Zirn et al. [56] and Angermeier et al. [17] showed that sound Localization in Bimodal Listeners could be improved instantaneously when the device delay mismatch (between CI and contralateral HA) was reduced.
Binaural interaction in noisy conditions has been studied by simulating a CI in single-sided deafness [57]. This was obtained by delivering a vocoded speech with variable degrees of mismatch in one ear of eight normal-hearing individuals and evaluating the speech audiometry in noise. The authors show that binaural performances are similar or significantly better than the normal-hearing ear in all cases. Furthermore, in challenging conditions (speech-shaped noise) where the normal ear performance is constrained to the level of the CI performance, a frequency mismatch further degrades the performances, probably by disrupting the binaural interactions. These observations suggest that, in patients with bimodal hearing, reducing the pitch perception mismatch between the CI and the acoustic inputs might enhance hearing in noisy conditions [57].
Even in patients with single-sided deafness (SSD), the contribution of the CI to auditory performances is significant [58,59]. CI decreases the head-shadow effect [58]; increases speech understanding in noise, even in the S0N0 condition (frontal signal and noise) [58,60]; enhances the sound-source localization [58,61]; and improves the patient-reported outcome [62]. In our patients with SSD (patient number 5, 16, and 21), optimization also showed a significant improvement in speech discrimination, except for patient 21 who still felt a subjective improvement with EA fMAP and thus, finally chose it. In line with previous reports, this observation supports the idea that optimized binaural interactions increase performance even with one normal ear.
The idea behind the change in the frequency bands was to optimize the correspondence between the ears and the binaural hearing. Testing these patients in a monaural condition would have probably provided additional interesting data. By reducing channel interactions or by a better correspondence between frequency allocations and functional channels, the EA-based fMAP could also improve monaural hearing.
In a theoretical approach, many have attempted to address the issue of binaural optimization by restoring the pitch-place function of the implanted cochlea according to the original cochlear tonotopy [23,63]. But by looking closer at this problem, the location of the spiral ganglion may be more relevant to the CI stimulation, and its distribution map follows a distinct function from the Greenwood map [63,64]. Nevertheless, attempts to optimize the binaural hearing through frequency allocation according to either the Greenwood or the spiral ganglion map have yielded poor results in general, despite a few individual positive effects on speech discrimination in noise [24,63,65].
Several explanations can be advanced for this failure. The electrode array covers, at best, partially the cochlear apex coding for the low frequencies. Consequently, adjusting the fMAP to the Greenwood function means neglecting a significant part of the spectrum in low and mid frequencies [24]. In the case of shallow insertion, a full and slightly compressed spectral distribution seems to provide better results than a truncated fMAP following Greenwood [24]. Another reason is the number of functional channels (i.e., electrodes eliciting a distinctive pitch) in the implanted cochlea. Theoretically, to each electrode and frequency band should correspond a distinctive auditory nerve ending, but this assumption is far from true in many clinical situations, and frequencies allocated to “dead zones” are lost [66]. Moreover, channel interactions in these cases increase signal distortions and binaural mismatches [66]. Interestingly, the EA-based fitting program indicated an enlargement of frequency bands allocated to several electrodes in our series. We hypothesize that by minimizing the frequency allocation to the electrodes which do not stimulate a distinct neural population, the dissonance decreased, and the hearing improved as it has been already reported [14]. Finally, fitting based on the Greenwood map does not improve the binaural fusion in comparison to the default CI settings since complex central processing adaptations seem to modify the binaural interactions. In patients with bimodal binaural hearing or bilateral CI, two notes separated as far as three or four octaves presented simultaneously to both ears can be perceived with a similar pitch [20,21]. The extent of these alterations depends on many interconnected factors, such as ipsi- and contralateral auditory performances (i.e., speech discrimination, pitch resolution) and the hearing deprivation period [20,21].
In contrast to the theoretical approaches based on the Greenwood map, frequency band adjustments have been also tackled through a purely empirical approach [67,68,69]. By studying the correlations between speech and electrode discrimination abilities, several authors could show that low-frequency resolution is a significant factor for speech discrimination in quiet and noise [60,62]. Allocating most of the electrodes to low frequencies (9 out of 10 to frequencies < 2.6 kHz) improved only some aspects of hearing (e.g., vowel discrimination, speech in noise) at the expense of other performances, such as consonant discrimination [69]. Modifying this strategy by affecting only three additional electrodes to low frequencies in comparison to the default setting had small and variable effects [68]. EA appeared to be more performant than empirical systematic protocols by exploiting patient interaction at each step.
In line with studies that suggest that low-frequency resolution is determinant in speech discrimination, pitch-matching studies showed that perceived pitches with CI were lower than what was estimated by the place-pitch function in unilateral CI users with a normal contralateral hearing [70,71,72]. Several clinical studies demonstrated that the adaptation of the peripheral and the central tonotopies to the radical changes of frequency mapping after CI are possible in the majority. This adaptation drives the new tonotopy toward the frequency organization imposed by the CI [72,73,74,75]. Tonotopy adjustments can involve the entire cochlea or only a region [73]. Some patients may not adapt or adapt poorly to these modifications [73] and understanding the reasons for this maladaptation remains a challenge. However, recent results on SSD and bilateral CI suggest poor plasticity of the binaural system to mismatch [74].
In quiet, the maximum speech discrimination was not influenced by the EA-based fitting. This can be explained by the ceiling effect (9.04 ± 2.01 initially versus 9.22 ± 1.76 at the final test). The best fMAP was not always obtained at the last generation (Table 2). In six patients, the first generation of fMAPs (parents), which were generated randomly in the predefined domain, yielded the best results. In these cases, the algorithm could not further improve the result probably due to the ceiling effect again. Indeed, these patients were initially selected with contralateral functional hearing and consequently, had high performances in quiet. The other possible reason is that, while in quiet, patients may rely on their better ear, and in noise, improvement of binaural hearing has a measurable impact on the performance [75]. But if we limit the analyses to the patient who had their best fMAP after the parent generation, we still have a significant improvement for WRS in noise (mean difference = 2.86), APHAB and HISQUI scores, and no difference for tests in silence, which means that there is no reason to exclude those patients. Patients included during the second phase of the study also had WRS in noise with both their default fMAP and EA fMAP at six weeks. If we compare those scores, we still get a significant improvement with the EA fMAP, which confirms that there is an advantage of the EA fitting. Since different word lists were used at each test, a higher repetition of speech tests in noise versus only two tests in quiet does not affect its outcome and does not appear as a plausible cause of bias [76].
Although EA-based fitting procedure is long and can only be applied to motivated patients, conventional protocols of binaural pitch-matching are even more time-consuming, and more difficult [72,77]. Indeed, they require prolonged concentration and the ability to compare pitches of electrical and acoustic sound regardless of their timber, texture, and loudness [77,78]. Unlike these tedious tasks, we chose the discrimination of 10 monosyllabic words in noise which was short but relevant to our objective. On one hand, the performance of the algorithm depended on the reliability of the scores, on the other hand, short tests have the disadvantage of lower test-retest reliability [79]. This tradeoff appeared interesting since it produced a significant improvement in the hearing in noise.
Recently, inter-aural place mismatch was evaluated in bilateral CI and SSD patients with unilateral CI [78] using ITD discrimination (simultaneous bilateral stimulation), place-pitch ranking (sequential bilateral stimulation), and physical electrode location estimated by CT scans. The results showed that binaural processing may be optimized by using CT scan information to program the CI frequency allocation but not place-pitch ranking. However, the study was not carried out with bimodal users (CI + HA). Moreover, a place-matched frequency mapping based on electrode location could be limited due to the difficulty to determine neural survival at the site of each electrode or the electric interactions in the cochlea for individual patients [10]. EA is directly based on the speech discrimination in noise, and thus, might exploit its extrinsic characteristics to optimize the fitting.
The relationship between loudness and pitch can also add complexity to the modifications of frequency band allocations: pitch and loudness are both affected by the rate of stimulation [80,81,82]. Modifying the frequency allocation alters the loudness perception in a non-linear and unpredictable manner [82]. We did not control or investigate the loudness alterations induced by the frequency band shifts because adding loudness adjustments to frequency band modifications would have exponentially increased the possible combinations in the algorithm and would have made the protocol inapplicable. This could be a subject of future research and development in EA-based fitting.
In the future, the algorithm could be integrated into the fitting software to accelerate the procedure and improve its acceptability by the patients. Evaluation procedures other than the WRS, such as musical sound categorization tasks, could be evaluated to improve the process.

5. Conclusions

By modifying the default fMAP, the evolutionary algorithm increased the word recognition score in noise and improved APHAB and HISQUI scores. Most of the patients (23 out of 27) preferred the modified fMAP and kept it at the end of the study. These improvements were observed despite the heterogeneity of the CI brands and the contralateral ear condition. These results open insights on integrating this type of approach in standard CI fitting.

Author Contributions

Conceptualization, V.P., P.L. and A.B.G.; methodology, V.P.; software, P.L.; validation, A.B.G.; formal analysis, P.L. and L.S.A.G.; investigation, A.B.G.; resources, P.L.; data curation, V.P.; writing—original draft preparation, A.S. (Alexis Saadoun), A.S. (Antoine Schein) and A.B.G.; writing—review and editing, A.B.G.; visualization, A.B.G.; supervision, A.B.G.; project administration, A.B.G.; funding acquisition, none. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The protocol was reviewed and approved by the Institutional Ethics Committee Board (CPP EST III, Nancy University Hospital, France, number: 2017-Jan-14444ND and CPP OUEST V, Rennes University Hospital, France, number: 2020-A00586-33).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Acknowledgments

The authors thank Julie Eluecque-Toletti, Claude Gagneux, Adrian Travo, Geoffrey Guenser, and Cyril Cornu for their technical assistance during the fittings.

Conflicts of Interest

Vincent Péan is a full-time Medel employee. The authors declare no other commercial or financial relationships that could be construed as a potential conflict of interest in this research project.

Appendix A

Table A1. Frequency bands adjustments with the evolutionary algorithm. Values are expressed in Hertz, e# (electrode number), BW (Band Width), fLOW (Lower Limit, Hz), fHIGH (Upper Limit, Hz), CF (Center Frequency, Hz). -: deactivated electrodes.
Table A1. Frequency bands adjustments with the evolutionary algorithm. Values are expressed in Hertz, e# (electrode number), BW (Band Width), fLOW (Lower Limit, Hz), fHIGH (Upper Limit, Hz), CF (Center Frequency, Hz). -: deactivated electrodes.
e#Initial fLOW Initial fHIGH Final fLOW Final fHIGH Initial BWFinal BWInitial CFFinal CF
Patient 1
110020810019510895154147.5
2208352195332144137280263.5
3352545332484193152448.5408
4545806484655261171675.5569.5
58061160655984354329983819.5
61160164398416194836351401.51301.5
7164323031619191766029819731768
8230332081917304890511312755.52482.5
932084450304840691242102138293558.5
104450615540696076170520075302.55072.5
116155850060768500234524247327.57288
12--------
Patient 2
110020810019310893154146.5
220835219328414491280238.5
3352545284528193244448.5406
4545806528795261267675.5661.5
580611607951085354290983940
611601643108515634834781401.51324
7164323031563218466062119731873.5
823033208218428119056272755.52497.5
932084450281141431242133238293477
10445061554143513417059915302.54638.5
116155850051348500234533667327.56817
12--------
Patient 3
1188313188298125110250.5243
2313438298409125111375.5353.5
343856340947112562500.5440
4563688471617125146625.5544
5688813617722125105750.5669.5
6813938722871125149875.5796.5
7938106387110011251301000.5936
81063118810011067125661125.51034
91188131310671129125621250.51098
10131315631129146225033314381295.5
11156318131462166925020716881565.5
12181320631669178725011819381728
13206323131787190525011821881846
1423132688190524183755132500.52161.5
1526883063241830303756122875.52724
1630633563303030925006233133061
17356340633092385550076338133473.5
1840634688385546086257534375.54231.5
1946885313460850926254845000.54850
20531360635092595975086756885525.5
2160636938595964608755016500.56209.5
2269387938646079381000147874387199
Patient 4
1188313220368125148250.5294
231343836846212594375.5415
3438563462605125143500.5533.5
4563688605770125165625.5687.5
568881377083212562750.5801
6813938832999125167875.5915.5
7938106399911751251761000.51087
81063118811751268125931125.51221.5
911881313126814131251451250.51340.5
10131315631413170225028914381557.5
11156318131702200125029916881851.5
1218132063200120632506219382032
13206323132063239025032721882226.5
1423132688239027723753822500.52581
1526883063277231073753352875.52939.5
16306335633107383450072733133470.5
17356340633834427450044038134054
1840634688427450336257594375.54653.5
1946885313503355806255475000.55306.5
20531360635580653275095256886056
21606369386532773487512026500.57133
226938793877347938100020474387836
Patient 5
1500647500626147126573.5563
2647837626777190151742701.5
38371083777973246196960875
410831401973116631819312421069.5
514011812116614934113271606.51329.5
618122345149321095336162078.51801
723453034210926146895052689.52361.5
830343925261433378917233479.52975.5
93925507833374687115313504501.54012
1050786570468758771492119058245282
1165708500587785001930262375357188.5
12--------
Patient 6
1195326195326131131260.5260.5
2326456326456130130391391
3456586456586130130521521
4586716586716130130651651
5716846716846130130781781
6846977846977131131911.5911.5
79771107977110713013010421042
8110713671107123726013012371172
913671758123716283913911562.51432.5
10175821481628201839039019531823
1121482539201824093913912343.52213.5
1225393060240929305215212799.52669.5
1330603711293035816516513385.53255.5
1437114492358144927819114101.54036.5
154492540444925534912104249485013
16540461855534657678110425794.56055
1761857357657676171172104167717096.5
18--------
19--------
20--------
Patient 7
118831318826112573250.5224.5
2313438261424125163375.5342.5
3438563424555125131500.5489.5
456368855564312588625.5599
5688813643754125111750.5698.5
6813938754871125117875.5812.5
79381063871933125621000.5902
81063118893310951251621125.51014
91188131310951157125621250.51126
10131315631157140825025114381282.5
1115631813140814702506216881439
12181320631470166725019719381568.5
13206323131667204825038121881857.5
1423132688204822553752072500.52151.5
1526883063225526033753482875.52429
16306335632603344250083933133022.5
17356340633442363450019238133538
1840634688363440796254454375.53856.5
19468853134079513362510545000.54606
20531360635133561475048156885373.5
2160636938561462668756526500.55940
2269387938626679381000167274387102
Patient 8
1250416238374166136333306
241649437451078136455442
34945875105789368540.5544
4587697578782110204642680
569782878285013168762.5816
682898385091815568905.5884
7983116891811211852031075.51019.5
811681387112113932192721277.51257
913871648139315292611361517.51461
10164819581529200531047618031767
11195823262005234536834021422175
12232627622345282143647625442583
1327623281282131615193403021.52991
14328138583161506457719033569.54112.5
153858463050648054772299042446559
164630870080548700407064666658377
Patient 9
1250416238374166136333306
241649437451078136455442
34945875105789368540.5544
458769757864611068642612
5697828646782131136762.5714
682898378285015568905.5816
7983116885010541852041075.5952
811681387105411892191351277.51121.5
913871648118916652614761517.51427
10164819581665186931020418031767
11195823261869241336854421422141
12232627622413254943613625442481
1327623281254931615196123021.52855
14328138583161526857721073569.54214.5
153858463052688054772278642446661
164630870080548700407064666658377
Patient 10
1188313188354125166250.5271
231343835444812594375.5401
3438563448658125210500.5553
4563688658816125158625.5737
5688813816927125111750.5871.5
68139389271080125153875.51003.5
7938106310801158125781000.51119
8--------
910681188115812201206211281189
10118814381220148025026013131350
11143816881480177525029515631627.5
12168819381775216025038518131967.5
13193821882160229925013920632229.5
1421882563229929973756982375.52648
152563293829973081375842750.53039
16293834383081407750099631883579
17343839384077419750012036884137
1839384563419749646257674250.54580.5
19456353134964576275079849385363
205313606357626809750104756886285.5
2160636938680977028758936500.57255.5
226938793877027938100023674387820
Patient 11
1188313188368125180250.5278
2313438368509125141375.5438,5
343856350958412575500.5546.5
4563688584747125163625.5665.5
568881374781612569750.5781.5
6813938816995125179875.5905.5
7938106399511271251321000.51061
81063118811271226125991125.51176.5
91188131312261313125871250.51269.5
10131315631313167425036114381493.5
11156318131674184725017316881760.5
12181320631847231025046319382078.5
13206323132310253125022121882420.5
1423132688253130793755482500.52805
1526883063307934943754152875.53286.5
16306335633494401850052433133756
1735634063401840905007238134054
1840634688409047526256624375.54421
1946885313475256116258595000.55181.5
205313606356116706750109556886158.5
21606369386706784687511406500.57276
22693879387846793810009274387892
Patient 12
17017070170100100120120
2170300170325130155235247.5
3300469325487169162384.5406
4469690487702221215579.5594.5
56909827021058292356836880
698213681058145338639511751255.5
713681881145319195134661624.51686
8188125641919307668311572222.52497.5
925643475307637059116293019.53390.5
1034754693370549711218126640844338
1146936321497165601628158955075765.5
126321850065608500217919407410.57530
Patient 13
1188313188358125170250.5273
2313438358493125135375.5425.5
343856349358412591500.5538.5
4563688584748125164625.5666
5688813748894125146750.5821
681393889495612562875.5925
7938106385611381252821000.5997
810631188113813181251801125.51228
911881313131815411252231250.51429.5
10131315631541180825026714381674.5
1115631813180818702506216881839
12181320631870237325050319382121.5
13206323132373249025011721882431.5
1423132688249027933753032500.52641.5
1526883063279332163754232875.53004.5
16306335633216400250078633133609
17356340634002444750044538134224.5
1840634688444750176255704375.54732
19468853135017619662511795000.55606.5
20531360636196682775063156886511.5
2160636938682776548758276500.57240.5
226938793876547938100028474387796
Patient 14
1188313188315125127250.5251.5
2313438315512125197375.5413.5
3438563512688125176500.5600
456368868876112573625.5724.5
5688813761936125175750.5848.5
68139389361077125141875.51006.5
7938106310771146125691000.51111.5
810631188114612961251501125.51221
91188131312961358125621250.51327
10131315631358176225040414381560
1115631813176218242506216881793
12181320631824217725035319382000.5
13206323132177233425015721882255.5
1423132688233427403754062500.52537
1526883063274035673758272875.53153.5
16306335633567405850049133133812.5
17356340634058432050026238134189
18406346884320534962510294375.54834.5
1946885313534955796252305000.55464
205313606355796595750101656886087
2160636938659574678758726500.57031
226938793874677938100047174387702.5
Patient 15
17017070197100127120133.5
2170300197354130157235275,5
3300469354480169126384.5417
4469690480816221336579.5648
56909828161105292289836960.5
698213681105139438628911751249.5
713681881139419855135911624.51689.5
818812564198528056838202222.52395
9256434752805396591111603019.53385
1034754693396577221218375740845843.5
1146936321472266711628194955075696.5
126321850066718500217918297410.57585.5
Patient 16
1100221100244121144160.5172
2221386244409165165303.5326.5
3386615409728229319500.5568.5
46159357281015320287775871.5
593513831015145044843511591232.5
613832014145022846318341698.51867
72014290622843475892119124602879.5
82906416934754569126310943537.54022
941695959456963091790174050645439
105959850063128500254121887229.57406
11--------
12--------
Patient 17
1188313188337125149250.5262.5
2313438337501125164375.5419
343856350156312562500.5532
4563688563751125188625.5657
5688813751882125131750.5816.5
68139388821024125142875.5953
79381063102412271252031000.51125.5
8--------
9106313131227139725017011881312
10131315631397180825041114381602.5
11156318131808198425017616881896
1218132188198422033752192000.52093.5
1321882563220326533754502375.52428
14256330632653350550085228133079
15306335633505390050039533133702.5
1635634188390043156254153875.54107.5
17418849384315527575096045634795
18493858135275651987512445375.55897
195813681365197074100055563136796.5
20681379387074793811258647375.57506
21--------
22--------
Patient 18
17017070200100130120135
2170300200352130152235276
3300469352545169193384.5448.5
4469690545725221180579.5635
56909827251098292373836911.5
698213681098137438627611751236
713681881137420405136661624.51707
818812564204027246836842222.52382
925643475272435879118633019.53155.5
1034754693358748601218127340844223.5
1146936321486968551628198655075862
126321850068558500217916457410.57677.5
Patient 19
110019810023698136149168
2198325236387127151261.5311.5
3325491387538166151408462.5
4491710538823219285600.5680.5
57109998231147289324854.5985
699913831147147038432311911308.5
7138318931470214151067116381805.5
818932754214126628615212323.52401.5
9257434832662397590913133028.53318.5
10348346983975472712157524090.54351
114698632347277328162526015510.56027.5
126323850073288500217711727411.57914
Patient 20
1188313188313125125250.5250.5
2313438313454125141375.5383.5
3438563454665125211500.5559.5
4563688665814125149625.5739.5
568881381487612562750.5845
681393887695812582875.5917
7938106395811171251591000.51037.5
810631188111712851251681125.51201
9118814381285160925032413131447
10143816881609177625016715631692.5
11168819381776216725039118131971.5
1219382313216722763751092125.52221.5
1323132688227627423754662500.52509
14268831882742284250010029382792
1531883688284229045006234382873
16368643132904458862716843999.53746
17431350634588549275090446885040
18506359385492654187510495500.56016.5
195938693865417117100057664386829
2069387935711779389978217436.57527.5
21--------
22--------
Patient 21
1188313188313125125250.5250.5
2313438313447125134375.5380
3438563447578125131500.5512.5
4563688578781125203625.5679.5
5688813781893125112750.5837
681393889397312580875.5933
7938106397311611251881000.51067
81063118811611223125621125.51192
911881313122313271251041250.51275
10131315631327182925050214381578
11156318131829201625018716881922.5
12181320632016244625043019382231
13206323132446259925015321882522.5
1423132688259930013754022500.52800
1526883063300135623755612875.53281.5
16306335633562418950062733133875.5
17356340634189468850049938134438.5
1840634688468848666251784375.54777
19468853134866623262513665000.55549
20531360636232680675057456886519
21606369386806787687510706500.57341
22693879387876793810006274387907
Patient 22
17017070184100114120127
2170300184310130126235247
3300469310493169183384.5401.5
4469690493692221199579.5592.5
56909826921163292471836927.5
698213681163154738638411751355
713681881154722315136841624.51889
818812564223126476834162222.52439
9256434752647411591114683019.53381
1034754693411554391218132440844777
1146936321543970501628161155076244.5
126321850070508500217914507410.57775
Patient 23
1188313188361125173250.5274.5
2313438361507125146375.5434
343856350758412577500.5545.5
4563688584755125171625.5669.5
5688813755885125130750.5820
68139388851059125174875.5972
79381063105912141251551000.51136.5
81063118812141310125961125.51262
91188131313101372125621250.51341
10131315631372173825036614381555
11156318131738205025031216881894
1218132063205021302508019382090
13206323132130236825023821882249
1423132688236829563755882500.52662
1526883063295636763757202875.53316
16306335633676380550012933133740.5
17356340633805453850073338134171.5
1840634688453849756254374375.54756.5
19468853134975619662512215000.55585.5
20531360636196682775063156886511.5
2160636938682776548758276500.57240.5
226938793876547938100028474387796
Patient 24
1188313188315125127250.5251.5
2313438315517125202375.5416
3438563517641125124500.5579
4563688641781125140625.5711
5688813781942125161750.5861.5
68139389421077125135875.51009.5
79381063107711931251161000.51135
810631188119312961251031125.51244.5
91188131312961358125621250.51327
10131315631358176425040614381561
1115631813176418262506216881795
12181320631826219025036419382008
13206323132190235525016521882272.5
1423132688235527403753852500.52547.5
1526883063274035673758272875.53153.5
16306335633567402250045533133794.5
17356340634022428850026638134155
18406346884288534962510614375.54818.5
1946885313534955796252305000.55464
20531360635579653775095856886058
2160636938653774678759306500.57002
226938793874677938100047174387702.5
Patient 25
110019810021998119149159.5
2198325219341127122261.5280
3325491341519166178408430
4491710519797219278600.5658
57109997971052289255854.5924.5
699913831052161138455911911331.5
7138318931611226551065416381938
818932754226528888616232323.52576.5
925743483288834529095643028.53170
103483469834525197121517454090.54324.5
114698632351977158162519615510.56177.5
126323850071588500217713427411.57829
Patient 26
1100208100237108137154168.5
2208352237354144117280295.5
3352545354637193283448.5495.5
4545806637956261319675.5796.5
5806116095613173543619831136.5
611601643131718914835741401.51604
7164323031891264466075319732267.5
823033208264434599058152755.53051.5
932084450345950331242157438294246
104450615550336365170513325302.55699
116155850063658500234521357327.57432.5
12--------
Patient 27
1188313188328125140250.5258
2313438328490125162375.5409
3438563490599125109500.5544.5
4563813599927250328688763
5813106392711762502499381051.5
6106313131176132125014511881248.5
7131315631321158425026314381452.5
8156318131584196425038016881774
918132188196424103754462000.52187
1021882563241028983754882375.52654
11256330632898331250041428133105
12306335633312414750083533133729.5
1335634188414747896256423875.54468
144188493847895895750110645635342
1549385813589564308755355375.56162.5
165813681364307256100082663136843
17681379387256793811256827375.57597
18--------
19--------
20--------
21--------
22--------

Appendix B

Table A2. The electrode position on post-operative CT scanner, center frequency deduced from the Greenwood map, default central frequency, and central frequency after fitting. BML (basilar membrane length) in mm, e# (electrode number), ERD (electrode to round window distance) in mm, GF (center frequency according to Greenwood equation) in Hz, DF (default center frequency) in Hz, EAF (Evolutionary Algorithm center frequency). -: deactivated electrodes.
Table A2. The electrode position on post-operative CT scanner, center frequency deduced from the Greenwood map, default central frequency, and central frequency after fitting. BML (basilar membrane length) in mm, e# (electrode number), ERD (electrode to round window distance) in mm, GF (center frequency according to Greenwood equation) in Hz, DF (default center frequency) in Hz, EAF (Evolutionary Algorithm center frequency). -: deactivated electrodes.
IDCI Brand/Array BML e#ERDGFDFEAF
1MEDEL/Flex 2830.711.5616,140.97327.57288
23.5311,796.25302.55072.5
35.678379.2738293558.5
47.765988.132755.52482.5
59.734351.8919731768
611.783110.851401.51301.5
713.972160.84983819.5
816.041519.15675.5569.5
918.271026.09448.5408
1020.3705.461280263.5
1122.41464.833154147.5
2MEDEL/Flex 2830.712.3714,276.17327.56817
24.4210,350.75302.54638.5
36.557399.6438293477
48.455475.082755.52497.5
510.53945.2119731873.5
612.52854.921401.51324
714.711984.74983940
816.671426.68675.5661.5
918.511036.59448.5406
1020.47726.911280238.5
1122.32509.428154146.5
3COCHLEAR/42226.613.2611,366.974387199
24.299401.16500.56209.5
35.09810956885525.5
45.976888.735000.54850
56.855848.854375.54231.5
67.65084.8638133473.5
78.44376.9433133061
89.213757.732875.52724
910.023223.312500.52161.5
1010.942704.4921881846
1111.762309.819381728
1212.591965.9316881565.5
1313.531634.2714381295.5
1414.391376.691250.51098
1515.061202.131125.51034
1615.81032.511000.5936
1716.4910.776875.5796.5
1817.16744.471750.5669.5
1918.08632.784625.5544
2018.75543.532500.5440
2118.92522.563375.5353.5
2218.11628.511250.5243
5MEDEL/Flex 2834.212.0215,503.975357188.5
24.1211,483.758245282
36.348350.894501.54012
48.636000.883479.52975.5
510.474592.952689.52361.5
612.463430.862078.51801
714.172662.781606.51329.5
816.751804.4112421069.5
918.911291.24960875
1020.97928.2742701.5
1123.15643.389573.5563
8AB/HiFOCUS Mid-scala28.612.2214,160.866658377
23.3211,732.942646559
34.110,265.33589.54112.5
44.98948.253021.52991
55.917520.7225442583
66.866383.1921422175
77.95330.4718031767
88.934455.281517.51461
99.993700.41277.51257
1010.83208.181075.51019.5
1111.82686.5905.5884
1212.82245.98762.5816
1313.81873.97642680
1414.81559.83540.5544
1515.81294.56455442
1616.81070.55333306
9AB/HiFOCUS Mid-scala27.511.515,849.766658377
22.513,270.642646661
33.4611,186.73589.54214.5
44.469359.483021.52855
55.57770.9925442481
66.56494.5121422141
77.565365.418031767
88.324676.041517.51427
99.263941.481277.51121.5
1010.443175.681075.5952
1111.272724.68905.5816
1212.32249.21762.5714
1313.281870.15642612
1414.321533.28540.5544
1515.081323.28455442
1616.121077.81333306
11COCHLEAR/CI52226.814.229578.8774387892
24.459183.586500.57276
35.837127.3456886158.5
46.356476.015000.55181.5
56.785981.714375.54421
69.293750.1638134054
79.883356.7733133756
810.82821.12875.53286.5
912.42077.212500.52805
1013.41710.2621882420.5
1114.41403.8919382078.5
1215.21195.6316881760.5
1316.2974.2214381493.5
1417.51738.511250.51269.5
1518.12646.371125.51176.5
1619.12515.631000.51061
1719.9428.83875.5905.5
1820.6360.68750.5781.5
1920.12406.48625.5665.5
2021.58278.64500.5546.5
2122.2233.74375.5438.5
2223.3165.46250.5278
13COCHLEAR/CI52223.211.7114,434.2274387796
22.4212,428.746500.57240.5
33.3910,127.0856886511.5
44.178585.745000.55606.5
54.967260.214375.54732
65.66335.438134224.5
76.445294.5133133609
87.194507.272875.53004.5
98.123687.412500.52641.5
109.152946.8921882431.5
1110.12391.3919382121.5
1211.21871.6116881839
13121561.8214381674.5
1413.11212,001250.51429.5
1514979.811125.51228
1614.9787.331000.5997
1715.7644.06875.5925
1816.7495.5750.5821
1917.3420.14625.5666
2018.2323.39500.5538.5
2119.2235.16375.5425.5
2220176.69250.5273
14COCHLEAR/CI52229.216.846562.8274387702.5
27.925464.236500.57031
38.864655.5856886087
49.644073.825000.55464
510.73394.544375.54834.5
611.72854.2838134189
712.22615.933133812.5
813.12233.542875.53153.5
9141904.122500.52537
1014.71679.7821882255.5
1115.61427.0419382000.5
1216.71165.1616881793
1317.8946.8914381560
1419750.011250.51327
1520613.331125.51221
1620.7530.271000.51111.5
1721.7427.13875.51006.5
1822.6347.84750.5848.5
1923.4286.62625.5724.5
2024245.74500.5600
2125.1180.58375.5413.5
2225.9140.11250.5251.5
15MEDEL/Flex 2828.4510.7518,184.987410.57585.5
22.8912,595.7555075696.5
34.858985.8840845843.5
47.076115.863019.53385
59.244184.532222.52395
611.22957.731624.51689.5
713.61918.2511751249.5
816.41136.75836960.5
918.2798.78579.5648
1020.4504.18384.5417
1122.5309.15235275.5
1224.4183.66120133.5
16MEDEL/Flex 2828.210.8717,791.387229.57406
22.3913,675.9950645439
34.689187.523537.54022
46.826320.8524602879.5
58.74538.941698.51867
6113012.2611591232.5
713.22019.94775871.5
815.41339.44500.5568.5
918805.29303.5326.5
1020.2506.49160.5172
1122.3309.32--
1224.2182.85--
17COCHLEAR/CI52224.812.6412,299.22--
23.5210,337.09--
34.338805.667375.57506
45.197423.8163136796.5
56.116180.845375.55897
66.915267.1545634795
77.784422.643875.54107.5
88.673694.8933133702.5
99.772953.5528133079
1010.82389.682375.52428
1111.62023.532000.52093.5
1212.61639.2916881896
1313.51352.0214381602.5
1414.51086.7311881312
1515.4888.4--
1616.5688.811000.51125.5
1717.3568.31875.5953
1818.1465.21750.5816.5
1918.8387.29625.5657
2019.6310.33500.5532
2120.4244.49375.5419
2221.2188.16250.5262.5
21COCHLEAR/CI52228.115.487964.0274387907
26.246969.876500.57341
37.335752.9556886519
48.274872.015000.55549
59.344028.214375.54777
610.53272.9638134438.5
711.32833.3133133875.5
812.52277.552875.53281.5
913.61859.682500.52800
1014.51571.9821882522.5
1115.41325.5619382231
1216.31114.4916881922.5
1317.4897.1914381578
1418.2763.091250.51275
1519646.231125.51192
1619.8544.41000.51067
1720.7445.41875.5933
1821.6360.62750.5837
1922.7273.33625.5679.5
2023.2238.79500.5512.5
2124.1183.65375.5380
2224.9141.31250.5250.5
24COCHLEAR/CI52224.311.3315,835.274387702.5
22.4712,591.786500.57002
33.2810,695.6856886058
44.158972.325000.55464
54.847802.554375.54818.5
65.656619.3838134155
76.535532.6933133794.5
87.434601.632875.53153.5
98.443737.312500.52547.5
109.522986.4321882272.5
1110.32536.1519382008
1211.42008.9616881795
1312.21691.8914381561
1413.31330.671250.51327
1514.11113.421125.51244.5
1615.2865.921000.51135
1716717.06875.51009.5
1816.8590.11750.5861.5
1917.7469.49625.5711
2018.5378.97500.5579
2119.4292.97375.5416
2220.5206.76250.5251.5
26MEDEL/Flex 2825.41020,677.07--
22.1913,578.187327.57432.5
34.358951.275302.55699
45.247533.4938294246
57.015336.822755.53051.5
69.253433.5319732267.5
710.52675.591401.51604
812.11934.829831136.5
9141303.4675.5796.5
1016844.59448.5495.5
1118.3493.51280295.5
1220.3289.49154168.5

References

  1. Avan, P.; Giraudet, F.; Büki, B. Importance of Binaural Hearing. Audiol. Neurotol. 2015, 20, 3–6. [Google Scholar] [CrossRef] [PubMed]
  2. Kong, Y.-Y.; Stickney, G.S.; Zeng, F.-G. Speech and Melody Recognition in Binaurally Combined Acoustic and Electric Hearing. J. Acoust. Soc. Am. 2005, 117, 1351–1361. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Morera, C.; Manrique, M.; Ramos, A.; Garcia-Ibanez, L.; Cavalle, L.; Huarte, A.; Castillo, C.; Estrada, E. Advantages of Binaural Hearing Provided through Bimodal Stimulation via a Cochlear Implant and a Conventional Hearing Aid: A 6-Month Comparative Study. Acta Oto-Laryngol. 2005, 125, 596–606. [Google Scholar] [CrossRef] [PubMed]
  4. Neuman, A.C.; Waltzman, S.B.; Shapiro, W.H.; Neukam, J.D.; Zeman, A.M.; Svirsky, M.A. Self-Reported Usage, Functional Benefit, and Audiologic Characteristics of Cochlear Implant Patients Who Use a Contralateral Hearing Aid. Trends Hear. 2017, 21, 233121651769953. [Google Scholar] [CrossRef] [Green Version]
  5. Schafer, E.C.; Amlani, A.M.; Paiva, D.; Nozari, L.; Verret, S. A Meta-Analysis to Compare Speech Recognition in Noise with Bilateral Cochlear Implants and Bimodal Stimulation. Int. J. Audiol. 2011, 50, 871–880. [Google Scholar] [CrossRef]
  6. Van Hoesel, R.J.M. Contrasting Benefits from Contralateral Implants and Hearing Aids in Cochlear Implant Users. Hear. Res. 2012, 288, 100–113. [Google Scholar] [CrossRef]
  7. Zirn, S.; Arndt, S.; Aschendorff, A.; Wesarg, T. Interaural Stimulation Timing in Single Sided Deaf Cochlear Implant Users. Hear. Res. 2015, 328, 148–156. [Google Scholar] [CrossRef]
  8. Bernstein, J.G.W.; Goupell, M.J.; Schuchman, G.I.; Rivera, A.L.; Brungart, D.S. Having Two Ears Facilitates the Perceptual Separation of Concurrent Talkers for Bilateral and Single-Sided Deaf Cochlear Implantees. Ear Hear. 2016, 37, 289–302. [Google Scholar] [CrossRef] [Green Version]
  9. Spirrov, D.; Kludt, E.; Verschueren, E.; Büchner, A.; Francart, T. Effect of (Mis)Matched Compression Speed on Speech Recognition in Bimodal Listeners. Trends Hear 2020, 24, 2331216520948974. [Google Scholar] [CrossRef]
  10. Wess, J.M.; Brungart, D.S.; Bernstein, J.G.W. The Effect of Interaural Mismatches on Contralateral Unmasking With Single-Sided Vocoders. Ear Hear. 2017, 38, 374–386. [Google Scholar] [CrossRef]
  11. Gifford, R.H.; Dorman, M.F.; McKarns, S.A.; Spahr, A.J. Combined Electric and Contralateral Acoustic Hearing: Word and Sentence Recognition With Bimodal Hearing. J. Speech Lang. Hear. Res. 2007, 50, 835–843. [Google Scholar] [CrossRef] [Green Version]
  12. Ching, T.Y.C.; van Wanrooy, E.; Dillon, H. Binaural-Bimodal Fitting or Bilateral Implantation for Managing Severe to Profound Deafness: A Review. Trends Amplif. 2007, 11, 161–192. [Google Scholar] [CrossRef]
  13. Litovsky, R.Y.; Johnstone, P.M.; Godar, S.P. Benefits of Bilateral Cochlear Implants and/or Hearing Aids in Children: Beneficios de Los Implantes Cocleares Bilaterales y/o Auxiliares Auditivos En Niños. Int. J. Audiol. 2006, 45, 78–91. [Google Scholar] [CrossRef]
  14. Mok, M.; Grayden, D.; Dowell, R.C.; Lawrence, D. Speech Perception for Adults Who Use Hearing Aids in Conjunction With Cochlear Implants in Opposite Ears. J. Speech Lang. Hear. Res. 2006, 49, 338–351. [Google Scholar] [CrossRef]
  15. Kiefer, J.; Pok, M.; Adunka, O.; Stürzebecher, E.; Baumgartner, W.; Schmidt, M.; Tillein, J.; Ye, Q.; Gstoettner, W. Combined Electric and Acoustic Stimulation of the Auditory System: Results of a Clinical Study. Audiol. Neurotol. 2005, 10, 134–144. [Google Scholar] [CrossRef]
  16. Richard, C.; Ferrary, E.; Borel, S.; Sterkers, O.; Grayeli, A.B. Interaction Between Electric and Acoustic Cues in Diotic Condition for Speech Perception in Quiet and Noise by Cochlear Implantees. Otol. Neurotol. 2012, 33, 30–37. [Google Scholar] [CrossRef]
  17. Angermeier, J.; Hemmert, W.; Zirn, S. Sound Localization Bias and Error in Bimodal Listeners Improve Instantaneously When the Device Delay Mismatch Is Reduced. Trends Hear. 2021, 25, 233121652110161. [Google Scholar] [CrossRef]
  18. Francart, T.; McDermott, H.J. Psychophysics, Fitting, and Signal Processing for Combined Hearing Aid and Cochlear Implant Stimulation. Ear Hear. 2013, 34, 685–700. [Google Scholar] [CrossRef] [Green Version]
  19. Greenwood, D.D. A Cochlear Frequency-position Function for Several Species—29 Years Later. J. Acoust. Soc. Am. 1990, 87, 2592–2605. [Google Scholar] [CrossRef]
  20. Oh, Y.; Reiss, L.A.J. Binaural Pitch Fusion: Binaural Pitch Averaging in Cochlear Implant Users With Broad Binaural Fusion. Ear Hear. 2020, 41, 1450–1460. [Google Scholar] [CrossRef]
  21. Hartling, C.L.; Fowler, J.R.; Stark, G.N.; Glickman, B.; Eddolls, M.; Oh, Y.; Ramsey, K.; Reiss, L.A.J. Binaural Pitch Fusion in Children With Normal Hearing, Hearing Aids, and Cochlear Implants. Ear Hear. 2020, 41, 1545–1559. [Google Scholar] [CrossRef]
  22. Vaerenberg, B.; Smits, C.; De Ceulaer, G.; Zir, E.; Harman, S.; Jaspers, N.; Tam, Y.; Dillon, M.; Wesarg, T.; Martin-Bonniot, D.; et al. Cochlear Implant Programming: A Global Survey on the State of the Art. Sci. World J. 2014, 2014, 501738. [Google Scholar] [CrossRef] [Green Version]
  23. Veugen, L.C.E.; Chalupper, J.; Snik, A.F.M.; van Opstal, A.J.; Mens, L.H.M. Frequency-Dependent Loudness Balancing in Bimodal Cochlear Implant Users. Acta Oto-Laryngol. 2016, 136, 775–781. [Google Scholar] [CrossRef] [Green Version]
  24. Baskent, D.; Shannon, R.V. Speech Recognition under Conditions of Frequency-Place Compression and Expansion. J. Acoust. Soc. Am. 2003, 113, 2064–2076. [Google Scholar] [CrossRef] [Green Version]
  25. Falcón-González, J.C.; Borkoski-Barreiro, S.; Limiñana-Cañal, J.M.; Ramos-Macías, Á. Reconocimiento auditivo musical y melódico en pacientes con implante coclear, mediante nuevo método de programación de asignación frecuencial. Acta Otorrinolaringol. Esp. 2014, 65, 289–296. [Google Scholar] [CrossRef]
  26. Maarefvand, M.; Blamey, P.J.; Marozeau, J. Pitch Matching in Bimodal Cochlear Implant Patients: Effects of Frequency, Spectral Envelope, and Level. J. Acoust. Soc. Am. 2017, 142, 2854–2865. [Google Scholar] [CrossRef]
  27. Arndt, S.; Laszig, R.; Aschendorff, A.; Hassepass, F.; Beck, R.; Wesarg, T. Cochlear Implant Treatment of Patients with Single-Sided Deafness or Asymmetric Hearing Loss. HNO 2017, 65, 98–108. [Google Scholar] [CrossRef]
  28. Williges, B.; Wesarg, T.; Jung, L.; Geven, L.I.; Radeloff, A.; Jürgens, T. Spatial Speech-in-Noise Performance in Bimodal and Single-Sided Deaf Cochlear Implant Users. Trends Hear. 2019, 23, 233121651985831. [Google Scholar] [CrossRef] [Green Version]
  29. Yoon, Y.; Liu, A.; Fu, Q.-J. Binaural Benefit for Speech Recognition with Spectral Mismatch across Ears in Simulated Electric Hearing. J. Acoust. Soc. Am. 2011, 130, EL94–EL100. [Google Scholar] [CrossRef] [Green Version]
  30. Goupell, M.J.; Stoelb, C.A.; Kan, A.; Litovsky, R.Y. The Effect of Simulated Interaural Frequency Mismatch on Speech Understanding and Spatial Release From Masking. Ear Hear. 2018, 39, 895–905. [Google Scholar] [CrossRef]
  31. Bernstein, J.G.W.; Stakhovskaya, O.A.; Schuchman, G.I.; Jensen, K.K.; Goupell, M.J. Interaural Time-Difference Discrimination as a Measure of Place of Stimulation for Cochlear-Implant Users with Single-Sided Deafness. Trends Hear. 2018, 22, 233121651876551. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Francart, T.; Wiebe, K.; Wesarg, T. Interaural Time Difference Perception with a Cochlear Implant and a Normal Ear. J. Assoc. Res. Otolaryngol. 2018, 19, 703–715. [Google Scholar] [CrossRef] [PubMed]
  33. Dirks, C.E.; Nelson, P.B.; Winn, M.B.; Oxenham, A.J. Sensitivity to Binaural Temporal-Envelope Beats with Single-Sided Deafness and a Cochlear Implant as a Measure of Tonotopic Match (L). J. Acoust. Soc. Am. 2020, 147, 3626. [Google Scholar] [CrossRef] [PubMed]
  34. Bäck, T. Evolutionary Algorithms in Theory and Practice: Evolution Strategies, Evolutionary Programming, Genetic Algorithms; Oxford University Press: Oxford, UK, 1996; ISBN 978-0-19-509971-3. [Google Scholar]
  35. Legrand, P.; Bourgeois-Republique, C.; Péan, V.; Harboun-Cohen, E.; Levy-Vehel, J.; Frachet, B.; Lutton, E.; Collet, P. Interactive Evolution for Cochlear Implants Fitting. Genet. Program. Evolvable Mach. 2007, 8, 319–354. [Google Scholar] [CrossRef] [Green Version]
  36. Ramesh, A.; Kambhampati, C.; Monson, J.; Drew, P. Artificial Intelligence in Medicine. Ann. R. Coll. Surg. Engl. 2004, 86, 334–338. [Google Scholar] [CrossRef] [Green Version]
  37. Govaerts, P.J.; Vaerenberg, B.; De Ceulaer, G.; Daemers, K.; De Beukelaer, C.; Schauwers, K. Development of a Software Tool Using Deterministic Logic for the Optimization of Cochlear Implant Processor Programming. Otol. Neurotol. 2010, 31, 908–918. [Google Scholar] [CrossRef] [Green Version]
  38. Meeuws, M.; Pascoal, D.; Bermejo, I.; Artaso, M.; De Ceulaer, G.; Govaerts, P.J. Computer-Assisted CI Fitting: Is the Learning Capacity of the Intelligent Agent FOX Beneficial for Speech Understanding? Cochlear Implant. Int. 2017, 18, 198–206. [Google Scholar] [CrossRef]
  39. Riss, D.; Hamzavi, J.-S.; Blineder, M.; Honeder, C.; Ehrenreich, I.; Kaider, A.; Baumgartner, W.-D.; Gstoettner, W.; Arnoldner, C. FS4, FS4-p, and FSP: A 4-Month Crossover Study of 3 Fine Structure Sound-Coding Strategies. Ear Hear. 2014, 35, e272–e281. [Google Scholar] [CrossRef]
  40. Vandali, A.E.; Whitford, L.A.; Plant, K.L.; Clark, G.M. Speech Perception as a Function of Electrical Stimulation Rate: Using the Nucleus 24 Cochlear Implant System. Ear Hear. 2000, 21, 608–624. [Google Scholar] [CrossRef] [Green Version]
  41. Wilson, B.S.; Finley, C.C.; Lawson, D.T.; Wolford, R.D.; Eddington, D.K.; Rabinowitz, W.M. Better Speech Recognition with Cochlear Implants. Nature 1991, 352, 236–238. [Google Scholar] [CrossRef]
  42. Bozorg-Grayeli, A.; Guevara, N.; Bebear, J.-P.; Ardoint, M.; Saaï, S.; Hoen, M.; Gnansia, D.; Romanet, P.; Lavieille, J.-P. Clinical Evaluation of the XDP Output Compression Strategy for Cochlear Implants. Eur. Arch. Otorhinolaryngol. 2016, 273, 2363–2371. [Google Scholar] [CrossRef]
  43. Firszt, J.B.; Holden, L.K.; Reeder, R.M.; Skinner, M.W. Speech Recognition in Cochlear Implant Recipients: Comparison of Standard HiRes and HiRes 120 Sound Processing. Otol. Neurotol. 2009, 30, 146–152. [Google Scholar] [CrossRef] [Green Version]
  44. Fournier, J.E. Vocal audiometry, its technique and results. Rev. Otoneuroophtalmol. 1950, 22, 649–656. [Google Scholar]
  45. Vincent, C.; Gagné, J.-P.; Leroux, T.; Clothier, A.; Larivière, M.; Dumont, F.S.; Gendron, M. French-Canadian Translation and Validation of Four Questionnaires Assessing Hearing Impairment and Handicap. Int. J. Audiol. 2017, 56, 248–259. [Google Scholar] [CrossRef]
  46. Amann, E.; Anderson, I. Development and Validation of a Questionnaire for Hearing Implant Users to Self-Assess Their Auditory Abilities in Everyday Communication Situations: The Hearing Implant Sound Quality Index (HISQUI19). Acta Otolaryngol. 2014, 134, 915–923. [Google Scholar] [CrossRef]
  47. Brockmeier, S.J.; Nopp, P.; Vischer, M.; Baumgartner, W.; Stark, T.; Schoen, F.; Mueller, J.; Braunschweig, T.; Busch, R.; Getto, M.; et al. Correlation of speech and music perception in postlingually deaf Combi 40/40+ users. In Cochlear Implants: An Update; Kubo, T., Takahashi, Y., Iwaki, T., Eds.; Kugler Publications: The Hague, The Netherlands, 2002; pp. 459–464. [Google Scholar] [CrossRef]
  48. Holland, J.H. Adaptation in Natural and Artificial Systems an Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence; MIT Press: Cambridge, MA, USA, 1992; ISBN 978-0-262-58111-0. [Google Scholar]
  49. Goldberg, D.E. Genetic Algorithms in Search, Optimization, and Machine Learning; Addison-Wesley Pub. Co.: Boston, MA, USA, 1989; ISBN 978-0-201-15767-3. [Google Scholar]
  50. Schwefel, H.-P.; Rudolph, G. Contemporary Evolution Strategies. In Advances in Artificial Life; Morán, F., Moreno, A., Merelo, J.J., Chacón, P., Eds.; Lecture Notes in Computer Science; Springer: Berlin/Heidelberg, Germany, 1995; Volume 929, pp. 891–907. ISBN 978-3-540-59496-3. [Google Scholar]
  51. Schwefel, H.-P. Evolution and Optimum Seeking; Sixth-Generation Computer Technology Series; Wiley: New York, NY, USA, 1995; ISBN 978-0-471-57148-3. [Google Scholar]
  52. Emmerich, M.; Shir, O.M.; Wang, H. Evolution Strategies. In Handbook of Heuristics; Martí, R., Pardalos, P.M., Resende, M.G.C., Eds.; Springer International Publishing: Cham, Switzerland, 2018; pp. 89–119. ISBN 978-3-319-07123-7. [Google Scholar]
  53. Poli, R.; Langdon, W.B.; McPhee, N.F.; Koza, J.R. A Field Guide to Genetic Programming; Lulu Press: Morrisville, NC, USA, 2008; ISBN 978-1-4092-0073-4. [Google Scholar]
  54. Li, S.; Kang, L.; Zhao, X.-M. A Survey on Evolutionary Algorithm Based Hybrid Intelligence in Bioinformatics. BioMed Res. Int. 2014, 2014, 362738. [Google Scholar] [CrossRef] [Green Version]
  55. Faul, F.; Erdfelder, E.; Lang, A.-G.; Buchner, A. G*Power 3: A Flexible Statistical Power Analysis Program for the Social, Behavioral, and Biomedical Sciences. Behav. Res. Methods 2007, 39, 175–191. [Google Scholar] [CrossRef]
  56. Zirn, S.; Angermeier, J.; Arndt, S.; Aschendorff, A.; Wesarg, T. Reducing the Device Delay Mismatch Can Improve Sound Localization in Bimodal Cochlear Implant/Hearing-Aid Users. Trends Hear. 2019, 23, 233121651984387. [Google Scholar] [CrossRef] [Green Version]
  57. Ma, N.; Morris, S.; Kitterick, P.T. Benefits to Speech Perception in Noise From the Binaural Integration of Electric and Acoustic Signals in Simulated Unilateral Deafness. Ear Hear. 2016, 37, 248–259. [Google Scholar] [CrossRef]
  58. Firszt, J.B.; Holden, L.K.; Reeder, R.M.; Waltzman, S.B.; Arndt, S. Auditory Abilities after Cochlear Implantation in Adults with Unilateral Deafness: A Pilot Study. Otol. Neurotol. 2012, 33, 1339–1346. [Google Scholar] [CrossRef] [Green Version]
  59. Sladen, D.P.; Frisch, C.D.; Carlson, M.L.; Driscoll, C.L.W.; Torres, J.H.; Zeitler, D.M. Cochlear Implantation for Single-Sided Deafness: A Multicenter Study: Cochlear Implantation for SSD. Laryngoscope 2017, 127, 223–228. [Google Scholar] [CrossRef] [Green Version]
  60. Buss, E.; Dillon, M.T.; Rooth, M.A.; King, E.R.; Deres, E.J.; Buchman, C.A.; Pillsbury, H.C.; Brown, K.D. Effects of Cochlear Implantation on Binaural Hearing in Adults With Unilateral Hearing Loss. Trends Hear. 2018, 22, 233121651877117. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Litovsky, R.Y.; Moua, K.; Godar, S.; Kan, A.; Misurelli, S.M.; Lee, D.J. Restoration of Spatial Hearing in Adult Cochlear Implant Users with Single-Sided Deafness. Hear. Res. 2019, 372, 69–79. [Google Scholar] [CrossRef] [PubMed]
  62. Thompson, N.J.; Dillon, M.T.; Buss, E.; Rooth, M.A.; King, E.R.; Bucker, A.L.; McCarthy, S.A.; Deres, E.J.; O’Connell, B.P.; Pillsbury, H.C.; et al. Subjective Benefits of Bimodal Listening in Cochlear Implant Recipients with Asymmetric Hearing Loss. Otolaryngol. Head Neck Surg. 2020, 162, 933–941. [Google Scholar] [CrossRef] [PubMed]
  63. Grasmeder, M.L.; Verschuur, C.A.; Batty, V.B. Optimizing Frequency-to-Electrode Allocation for Individual Cochlear Implant Users. J. Acoust. Soc. Am. 2014, 136, 3313–3324. [Google Scholar] [CrossRef] [Green Version]
  64. Sridhar, D.; Stakhovskaya, O.; Leake, P.A. A Frequency-Position Function for the Human Cochlear Spiral Ganglion. Audiol. Neurotol. 2006, 11, 16–20. [Google Scholar] [CrossRef] [Green Version]
  65. Simpson, A.; McDermott, H.J.; Dowell, R.C.; Sucher, C.; Briggs, R.J.S. Comparison of Two Frequency-to-Electrode Maps for Acoustic-Electric Stimulation. Int. J. Audiol. 2009, 48, 63–73. [Google Scholar] [CrossRef]
  66. Moore, B.C.J. Coding of Sounds in the Auditory System and Its Relevance to Signal Processing and Coding in Cochlear Implants. Otol. Neurotol. 2003, 24, 243–254. [Google Scholar] [CrossRef]
  67. Henry, B.A.; McKay, C.M.; McDermott, H.J.; Clark, G.M. The Relationship between Speech Perception and Electrode Discrimination in Cochlear Implantees. J. Acoust. Soc. Am. 2000, 108, 1269. [Google Scholar] [CrossRef]
  68. Leigh, J.R.; Henshall, K.R.; McKay, C.M. Optimizing Frequency-to-Electrode Allocation in Cochlear Implants. J. Am. Acad. Audiol. 2004, 15, 574–584. [Google Scholar] [CrossRef] [Green Version]
  69. McKay, C.M.; Henshall, K.R. Frequency-to-Electrode Allocation and Speech Perception with Cochlear Implants. J. Acoust. Soc. Am. 2002, 111, 1036–1044. [Google Scholar] [CrossRef]
  70. Stakhovskaya, O.; Sridhar, D.; Bonham, B.H.; Leake, P.A. Frequency Map for the Human Cochlear Spiral Ganglion: Implications for Cochlear Implants. JARO 2007, 8, 220–233. [Google Scholar] [CrossRef] [Green Version]
  71. Vermeire, K.; Landsberger, D.M.; Van de Heyning, P.H.; Voormolen, M.; Kleine Punte, A.; Schatzer, R.; Zierhofer, C. Frequency-Place Map for Electrical Stimulation in Cochlear Implants: Change over Time. Hear. Res. 2015, 326, 8–14. [Google Scholar] [CrossRef] [Green Version]
  72. Dorman, M.F.; Spahr, T.; Gifford, R.; Loiselle, L.; McKarns, S.; Holden, T.; Skinner, M.; Finley, C. An Electric Frequency-to-Place Map for a Cochlear Implant Patient with Hearing in the Nonimplanted Ear. JARO 2007, 8, 234–240. [Google Scholar] [CrossRef] [Green Version]
  73. Tan, C.-T.; Martin, B.; Svirsky, M.A. Pitch Matching between Electrical Stimulation of a Cochlear Implant and Acoustic Stimuli Presented to a Contralateral Ear with Residual Hearing. J. Am. Acad. Audiol. 2017, 28, 187–199. [Google Scholar] [CrossRef] [Green Version]
  74. Bernstein, J.G.W.; Jensen, K.K.; Stakhovskaya, O.A.; Noble, J.H.; Hoa, M.; Kim, H.J.; Shih, R.; Kolberg, E.; Cleary, M.; Goupell, M.J. Interaural Place-of-Stimulation Mismatch Estimates Using CT Scans and Binaural Perception, But Not Pitch, Are Consistent in Cochlear-Implant Users. J. Neurosci. 2021, 41, 10161–10178. [Google Scholar] [CrossRef]
  75. Neher, T. Characterizing the Binaural Contribution to Speech-in-Noise Reception in Elderly Hearing-Impaired Listeners. J. Acoust. Soc. Am. 2017, 141, EL159–EL163. [Google Scholar] [CrossRef] [Green Version]
  76. Carbonell, K.M. Reliability of Individual Differences in Degraded Speech Perception. J. Acoust. Soc. Am. 2017, 142, EL461–EL466. [Google Scholar] [CrossRef]
  77. Carlyon, R.P.; Macherey, O.; Frijns, J.H.M.; Axon, P.R.; Kalkman, R.K.; Boyle, P.; Baguley, D.M.; Briggs, J.; Deeks, J.M.; Briaire, J.J.; et al. Pitch Comparisons between Electrical Stimulation of a Cochlear Implant and Acoustic Stimuli Presented to a Normal-Hearing Contralateral Ear. JARO 2010, 11, 625–640. [Google Scholar] [CrossRef] [Green Version]
  78. Green, T.; Faulkner, A.; Rosen, S. Frequency Selectivity of Contralateral Residual Acoustic Hearing in Bimodal Cochlear Implant Users, and Limitations on the Ability to Match the Pitch of Electric and Acoustic Stimuli. Int. J. Audiol. 2012, 51, 389–398. [Google Scholar] [CrossRef]
  79. Cronbach, L.J.; Warrington, W.G. Time-Limit Tests: Estimating Their Reliability and Degree of Speeding. Psychometrika 1951, 16, 167–188. [Google Scholar] [CrossRef]
  80. Arnoldner, C.; Kaider, A.; Hamzavi, J. The Role of Intensity Upon Pitch Perception in Cochlear Implant Recipients. Laryngoscope 2006, 116, 1760–1765. [Google Scholar] [CrossRef] [PubMed]
  81. Arnoldner, C.; Riss, D.; Kaider, A.; Mair, A.; Wagenblast, J.; Baumgartner, W.-D.; Gstöttner, W.; Hamzavi, J.-S. The Intensity–Pitch Relation Revisited: Monopolar Versus Bipolar Cochlear Stimulation. Laryngoscope 2008, 118, 1630–1636. [Google Scholar] [CrossRef] [PubMed]
  82. Neuhoff, J.G.; Wayand, J.; Kramer, G. Pitch and Loudness Interact in Auditory Displays: Can the Data Get Lost in the Map? J. Exp. Psychol. Appl. 2002, 8, 17–25. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Frequency MAP fitting by an evolutionary algorithm (EA). An example with 5 electrodes (e1 to e5) for an MED-EL device is presented. The initial frequency intervals (fLOW and fHIGH in Hz) and the exploration domains for fHIGH (upper limit of each frequency band) by the algorithm are shown. The fLOW was set equal to fHIGH of the previous electrode to avoid discontinuity and overlap.
Figure 1. Frequency MAP fitting by an evolutionary algorithm (EA). An example with 5 electrodes (e1 to e5) for an MED-EL device is presented. The initial frequency intervals (fLOW and fHIGH in Hz) and the exploration domains for fHIGH (upper limit of each frequency band) by the algorithm are shown. The fLOW was set equal to fHIGH of the previous electrode to avoid discontinuity and overlap.
Brainsci 12 00253 g001
Figure 2. The process of parent and children generation is shown through an example of an MED-EL CI with 5 electrodes. Scores are obtained by speech recognition in noise in a binaural free-field-like condition. * In the case of a tie, the first selected individual is retained (fHIGH mutation $).
Figure 2. The process of parent and children generation is shown through an example of an MED-EL CI with 5 electrodes. Scores are obtained by speech recognition in noise in a binaural free-field-like condition. * In the case of a tie, the first selected individual is retained (fHIGH mutation $).
Brainsci 12 00253 g002
Figure 3. Postoperative CT scans analysis and reconstruction: (a) Oblique view of the cochlea on a multiplanar reconstruction (MPR) with minimal intensity projection showed the full length of the electrode array; (b) A reconstruction of the image (a) in a curvilinear plane unfolded the cochlear spiral; The relative distance of each electrode to the round window (RW) was measured. Since the electrodes are not on the same plane, they cannot be all visualized on the MPR.
Figure 3. Postoperative CT scans analysis and reconstruction: (a) Oblique view of the cochlea on a multiplanar reconstruction (MPR) with minimal intensity projection showed the full length of the electrode array; (b) A reconstruction of the image (a) in a curvilinear plane unfolded the cochlear spiral; The relative distance of each electrode to the round window (RW) was measured. Since the electrodes are not on the same plane, they cannot be all visualized on the MPR.
Brainsci 12 00253 g003
Figure 4. Effect of evolutionary algorithm (EA) after mutations and evolutions on frequency bandwidth, and center frequencies for the 4 most apical electrodes (electrode 1 representing the most apical as in MED-EL and Advanced Bionics CIs). Values are expressed as mean ± standard error of mean (n = 27). * p < 0.05 for the effect of EA on band width, and *** p < 0.001 for the effect of EA on center frequencies; in both analyses, p < 0.001 for the effect of electrode number and no significant interaction, two-way ANOVA.
Figure 4. Effect of evolutionary algorithm (EA) after mutations and evolutions on frequency bandwidth, and center frequencies for the 4 most apical electrodes (electrode 1 representing the most apical as in MED-EL and Advanced Bionics CIs). Values are expressed as mean ± standard error of mean (n = 27). * p < 0.05 for the effect of EA on band width, and *** p < 0.001 for the effect of EA on center frequencies; in both analyses, p < 0.001 for the effect of electrode number and no significant interaction, two-way ANOVA.
Brainsci 12 00253 g004
Figure 5. Center frequencies of electrodes according to the Greenwood map calculated on the postoperative CT scan, the default setting, and the evolutionary algorithm (EA) in Cochlear ® (A, n = 7), MED-EL ® (B, n = 6) and Advanced bionics ® (C, n = 2) cochlear implants. Values are expressed as mean ± standard error of mean. For Advanced Bionic (panel C), individual values are depicted. Center frequencies according to the Greenwood map differed from default and EA settings. *** p < 0.001 for the effects of settings, electrode position, and interaction in all 3 brands, two-way ANOVA.
Figure 5. Center frequencies of electrodes according to the Greenwood map calculated on the postoperative CT scan, the default setting, and the evolutionary algorithm (EA) in Cochlear ® (A, n = 7), MED-EL ® (B, n = 6) and Advanced bionics ® (C, n = 2) cochlear implants. Values are expressed as mean ± standard error of mean. For Advanced Bionic (panel C), individual values are depicted. Center frequencies according to the Greenwood map differed from default and EA settings. *** p < 0.001 for the effects of settings, electrode position, and interaction in all 3 brands, two-way ANOVA.
Brainsci 12 00253 g005
Figure 6. APHAB questionnaire scores with default and evolutionary algorithm settings. Values are expressed as mean ± standard error of mean. *** p < 0.001 versus default for the global score, Wilcoxon signed-rank test. $$$ p < 0.001 for the effect of setting, and p < 0.01 for the effect of APHAB ranges, no significant interaction, 2-way ANOVA. EC = ease of communication, RV = reverberation, BN = background noise, AV = aversiveness.
Figure 6. APHAB questionnaire scores with default and evolutionary algorithm settings. Values are expressed as mean ± standard error of mean. *** p < 0.001 versus default for the global score, Wilcoxon signed-rank test. $$$ p < 0.001 for the effect of setting, and p < 0.01 for the effect of APHAB ranges, no significant interaction, 2-way ANOVA. EC = ease of communication, RV = reverberation, BN = background noise, AV = aversiveness.
Brainsci 12 00253 g006
Figure 7. Global evaluation of the sound quality and music perception with default and evolutionary algorithm settings. Values are expressed as mean ± standard error of mean. There is no significant effect of fitting on any item (Wilcoxon signed-rank test).
Figure 7. Global evaluation of the sound quality and music perception with default and evolutionary algorithm settings. Values are expressed as mean ± standard error of mean. There is no significant effect of fitting on any item (Wilcoxon signed-rank test).
Brainsci 12 00253 g007
Table 1. Patient characteristics.
Table 1. Patient characteristics.
ID#EtiologyHearing Deprivation on Implanted Ear (Years)ImplantCodingContralateral Hearing Aid
1Otosclerosis55MED-ELFS4 [39]Chili SP7, Oticon
2Congenital28MED-ELFS4Legend 1786, Beltone
3Congenital38COCHLEARACE [40]Naida Q70-SP, Phonak
4Ménière17COCHLEARACECobalt 8+, Rexton
5Congenital23MED-ELHDCIS [41]Normal
6Congenital43OTICONCrystalis XDP [42]Nitro 7MI SP, Siemens
7Congenital34COCHLEARACEAmbra SP, Phonak
8Sudden SNHL1ABHiRes Optima [43]Insio 5bX, Siemens
9Idiopathic16ABHiRes OptimaUPSmart988 GN Resound
10Lobstein’s disease42COCHLEARACEPHONAK Naida Q50 SP
11Congenital39COCHLEARACESiemens Signia Orion 2312
12Sudden SNHL18MED-ELFS4Widex Moment
13Congenital20COCHLEARACESiemens Pure 500
14Sudden SNHL30COCHLEARACEPhonak Naida V90 UP
15Sudden SNHL13MED-ELFS4Starkey Livio 2400
16Otosclerosis2MED-ELFS4Normal
17Otosclerosis7COCHLEARACEPhonak Audeo B50 R
18Neurofibromatosis type 219MED-ELFS4Phonak Naida Q70 SP
19Chronic otitis media42MED-ELFS4No hearing aid
20Perilymphatic fistula2COCHLEARACESiemens Rexton Strata 2
21Perilymphatic fistula9COCHLEARACENormal
22Chronic otitis media50MED-ELFS4Siemens Motion XS
23Congenital32COCHLEARACEGn Hearing Resound Alera 7
24Ménière2COCHLEARACEBelton Identity 86D
25Meningitis30MED-ELFS4Siemens Signia Pure 312
26Ménière17MED-ELFS4Starkey Resound
27Sudden SNHL5COCHLEARACEBelton Identity 66D
Table 2. WRS for each fMAP generated by the evolutionary algorithm (P1–4 and C1–C9). Asterisk indicates the selected final fMAP. Initial and final WRS (45–60 days after fitting) were tested by 20 words and intermediate WRS by 10 words. All were expressed as a score out of ten. All tests were conducted at the same signal/noise ratio (SNR). Minus sign (-): the patient was not willing to test the fMAPs and abandoned the procedure.
Table 2. WRS for each fMAP generated by the evolutionary algorithm (P1–4 and C1–C9). Asterisk indicates the selected final fMAP. Initial and final WRS (45–60 days after fitting) were tested by 20 words and intermediate WRS by 10 words. All were expressed as a score out of ten. All tests were conducted at the same signal/noise ratio (SNR). Minus sign (-): the patient was not willing to test the fMAPs and abandoned the procedure.
Patient NumberInitial WRS SNR (dB HL)Parents1st Generation2nd Generation3rd GenerationFinal WRS
P1P2P3P4C1C2C3C4C5C6C7C8C9
14106866869 *6777679
2557610 *946109-----6.5
341064555568 *788867.5
44053566 *4-------6
54−74458676559 *7688
6510024523456 *54055
7354767579 *6847677.5
85.5575674557567 *667.5
9510468 *55667877657.5
103102423545354349 *2
11610697556868889 *68
126−55435767447458 *7
13306255476267468 *7
143048 *624362436558
154−552468 *437541447
164−105412346 *4542357
175−5358 *34451373327
184−546 *252235155457
193−535448 *435543556
205−10111177 *45575655
2140252234423255 *43
22307 *3556544422667
2331042421378 *245147
245035733243467 *326
2550413454336 *44113
2630435426643247 *46
274−523345336 *414557
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Saadoun, A.; Schein, A.; Péan, V.; Legrand, P.; Aho Glélé, L.S.; Bozorg Grayeli, A. Frequency Fitting Optimization Using Evolutionary Algorithm in Cochlear Implant Users with Bimodal Binaural Hearing. Brain Sci. 2022, 12, 253. https://doi.org/10.3390/brainsci12020253

AMA Style

Saadoun A, Schein A, Péan V, Legrand P, Aho Glélé LS, Bozorg Grayeli A. Frequency Fitting Optimization Using Evolutionary Algorithm in Cochlear Implant Users with Bimodal Binaural Hearing. Brain Sciences. 2022; 12(2):253. https://doi.org/10.3390/brainsci12020253

Chicago/Turabian Style

Saadoun, Alexis, Antoine Schein, Vincent Péan, Pierrick Legrand, Ludwig Serge Aho Glélé, and Alexis Bozorg Grayeli. 2022. "Frequency Fitting Optimization Using Evolutionary Algorithm in Cochlear Implant Users with Bimodal Binaural Hearing" Brain Sciences 12, no. 2: 253. https://doi.org/10.3390/brainsci12020253

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop